Home/Pipeline/HIV Therapeutics

HIV Therapeutics

HIV/AIDS

ApprovedCommercial

Key Facts

Indication

HIV/AIDS

Phase

Approved

Status

Commercial

Company

Shionogi

About Shionogi

Shionogi Inc. is a global pharmaceutical company with over 140 years of experience in drug discovery and development, headquartered in Japan with significant US operations. The company specializes in addressing unmet medical needs through innovative treatments for infectious diseases, antivirals, and complex therapeutic areas. Shionogi has built strategic partnerships with industry, government agencies, and biotech companies to advance science with urgency, particularly in response to global health challenges like antimicrobial resistance and COVID-19. The company operates as a publicly traded entity with a strong commitment to ethical business practices and transparent operations.

View full company profile

Therapeutic Areas

Infectious Diseases Antivirals HIV/AIDS Influenza COVID-19 Fragile X Syndrome Acute Ischemic Stroke Metabolic Disorders Oncology Antibiotics

Other HIV/AIDS Drugs

Drug	Company	Phase	Status
ANKTIVA®	ImmunityBio	Phase 1	Active
ARV Portfolio	Aurobindo Pharma	Commercial	Active
ARV Portfolio (e.g., Dolutegravir, Tenofovir)	Laurus Labs	Commercial	Active
Antiretroviral (ARV) Portfolio	Strides Pharma	Approved	Commercial